Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,885,489
-$5,224,794 QoQ
Shares Held
2,154,713
+5.9% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#169
of 2,821 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. PFE ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,154,713 | $51,885,489 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,885,489 | 2,154,713 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $57,110,283 | 2,033,842 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,544,047 | 1,628,275 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $37,152,540 | 1,458,106 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,558,240 | 1,425,670 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,492,762 | 1,203,345 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,979,539 | 1,318,490 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,601,865 | 1,126,533 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,518,854 | 1,126,478 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,211,007 | 1,124,721 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $42,926,984 | 1,491,038 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,947,218 | 299,886 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,089,164 | 275,059 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,796,389 | 313,637 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,062,663 | 313,479 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,431,087 | 626,853 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $32,865,902 | 626,853 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $32,452,179 | 626,853 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $58,437,238 | 989,623 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $51,399,960 | 1,195,070 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,873,395 | 584,101 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $20,182,827 | 557,075 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $65,676,650 | 2,012,155 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||